Physician profile
Gary A Go
NPI 1134144033
$2,194.71
in general payments reported to CMS, 2019-2025
13 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $34.66 · 2021: $115 · 2022: $1,262 · 2023: $180 · 2024: $105 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $1,241.88 | 2022 | |
| Stryker Corporation | $340.19 | 2019-2025 | Variax, Pangea, Bio4 |
| Acumed LLC | $136.13 | 2023-2024 | Acumed, Osteomed |
| Pacira Therapeutics, INC. | $133.08 | 2019 | |
| Ferring Pharmaceuticals INC. | $90.59 | 2024-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $60.05 | 2025 | |
| Ethicon US, LLC | $39.36 | 2021-2022 | |
| Depuy Synthes Sales INC. | $34.02 | 2020-2021 | |
| Fidia Pharma USA INC. | $30.92 | 2025 | Hymovis |
| Davol INC. | $29.65 | 2021 | |
| Bioventus LLC | $24.43 | 2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $19.25 | 2024 | Exparel, Zilretta, Iovera |
| Sanofi-Aventis U.S. LLC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.